Tragara Pharmaceuticals Employee Directory

Biotechnology ResearchUnited States2-10 Employees

Tragara Pharmaceuticals, Inc. is a privately held pharmaceutical company based in San Diego, Calif.  The company is focused on the clinical and commercial development of proprietary medicines for the treatment of cancer. TG02 is a unique, oral multi-kinase inhibitor which combines the benefits of inhibiting important cyclin dependent kinases equipotently with JAK2, FLT3, and ERK5 inhibition. TG02 exerts its antitumor activity via its potent CDK9 inhibition, which leads to the depletion of key survival proteins, such as Mcl-1, resulting in p53-independent apoptosis of a wide range of tumor cells.  Tragara is managed by a team of entrepreneurs with both Big Pharma and Biotech experience in the development and commercialization of oncology therapeutics. Its investors include: Domain Associates, Mitsubishi International Corporation, Morganthaler Ventures, and ProQuest Investments. 

Tragara strives to provide much-needed therapies that will contribute to patient health through better survival and an increase in the quality of life.  For more information, visit www.tragarapharma.com.

Sign up for free to view info

Company overview Email format